Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

Amgen Announces Webcast Of 2018 First Quarter Financial Results


THOUSAND OAKS, Calif., April 19, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2018 financial results on Tuesday, April 24, 2018, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. 

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. 

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Kristen Davis, 805-447-3008 (media)
Kristen Neese, 805-313-8267 (media)
Arvind Sood, 805-447-1060 (investors)

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

 

SOURCE Amgen


These press releases may also interest you

at 08:48
For the eighth year in a row, the VIN Foundation, a 501(c)(3) nonprofit, has earned the Platinum Seal of Transparency from Candid. This highest level of recognition from Candid, the world's largest source of information on nonprofit organizations,...

at 08:46
Autism Digest, a cornerstone in the autism community, is thrilled to announce a series of celebratory initiatives as part of its significant 25th anniversary milestone. As a leader in providing insightful content for those affected by autism, Autism...

at 08:46
Midi Health, the fastest-growing virtual care clinic for women navigating perimenopause and menopause, today announced the close of a $60M Series B funding round led by Emerson Collective, bringing the company's total funding raised to date to $100M....

at 08:44
Hire Health, a healthcare-focused human capital solutions firm, announced its official launch today. With a passion for improving patient care and commitment to optimal business outcomes, Hire Health is uniquely positioned to assist healthcare and...

at 08:44
Leading hearing care retailer HearUSA announced today that it has won a 2024 Global Health & Pharma Private Healthcare Award in the Shopping & Retail category and has been named Best Nationwide Hearing Aid Solutions Company. This most recent award...

at 08:42
The 2023 Adsposure Transit Awards have concluded, and after a fierce two-week competition and thousands of votes, 29 campaigns were crowned first place winners! Transit advertising campaigns were nominated in four different categories for this...



News published on and distributed by: